MP4CO

DB17860InvestigationalProtein Based Therapies

MP4CO: Overview.

Mechanism: Pharmacologically active on Nuclear factor erythroid 2-related factor 2
Curator reviewed
Also known as: PEG carboxyhaemoglobin · Pegylated carboxyhaemoglobin

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with MP4CO, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.